Skip to main content
. 2023 Sep 19;13(9):e071330. doi: 10.1136/bmjopen-2022-071330

Table 2.

Secondary outcomes

Outcomes No chronic dysglycaemia
(n=61)
Chronic dysglycaemia P value*
Pre-diabetes
(n=114)
Unknown diabetes
(n=60)
Controlled diabetes
(n=25)
Uncontrolled diabetes
(n=48)
90-day mortality, n (%) 9 (14.7) 28 (24.5) 12 (20.0) 7 (28.0) 15 (31.2) 0.09
ICU length of stay, days 9 (4, 25) 14 (6, 24) 13 (6, 28) 8 (5, 21) 11 (7, 22) 0.69
Invasive mechanical ventilation, days 16 (8, 29) 14 (10, 23) 15 (10, 27) 15 (6, 21) 14 (9, 22) 0.60
Renal replacement therapy, n (%) 17 (27.9) 22 (19.3) 11 (18.3) 1 (4.0) 8 (16.6) 0.06

Data are n (%) or median (IQR).

ICU lengths of stay (4 missing values because of transfer to other hospital).

*P values for the comparison between no chronic dysglycaemia and chronic dysglycaemia, Mann-Whitney U test was used for comparison of continuous data and Fisher’s exact test for comparison of categorical data.

ICU, intensive care unit.